Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Walnut Protein Flour is an investigational allergen product used in oral immunotherapy (OIT) for the treatment of tree nut allergies. Developed by researchers at the University of North Carolina at Chapel Hill, the therapy involves the daily ingestion of incrementally increasing doses of walnut protein. This process is designed to induce clinical desensitization by modulating the patient's immune response, thereby increasing the threshold for allergic reactions upon accidental exposure to walnuts. The treatment also aims to provide cross-desensitization to other related tree nuts by leveraging shared allergenic epitopes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on walnut protein flour.